Marshall Wace, LLP Teva Pharmaceutical Industries LTD Transaction History

Marshall Wace, LLP

  • $72.2 Billion
  • Q2 2024

A detailed history of Marshall Wace, LLP transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Marshall Wace, LLP holds 4,172,593 shares of TEVA stock, worth $73 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
4,172,593
Previous 4,215,216 1.01%
Holding current value
$73 Million
Previous $59.5 Million 14.0%
% of portfolio
0.09%
Previous 0.09%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$12.78 - $17.4 $544,721 - $741,640
-42,623 Reduced 1.01%
4,172,593 $67.8 Million
Q1 2024

May 15, 2024
BUY
$10.67 - $14.43 $23 Million - $31.1 Million
2,152,814 Added 104.38%
4,215,216 $59.5 Million
Q4 2023

Feb 14, 2024
SELL
$8.12 - $10.63 $2.59 Million - $3.39 Million
-318,572 Reduced 13.38%
2,062,402 $21.5 Million
Q3 2023

Nov 14, 2023
BUY
$7.48 - $10.7 $8.84 Million - $12.6 Million
1,182,072 Added 98.6%
2,380,974 $24.3 Million
Q2 2023

Aug 14, 2023
BUY
$7.2 - $9.47 $8.63 Million - $11.4 Million
1,198,902 New
1,198,902 $9.03 Million
Q4 2022

Feb 14, 2023
BUY
$7.95 - $9.48 $10,120 - $12,068
1,273 Added 2.68%
48,771 $444,000
Q3 2022

Nov 14, 2022
SELL
$6.86 - $11.95 $14.1 Million - $24.5 Million
-2,052,207 Reduced 97.74%
47,498 $383,000
Q2 2022

Aug 15, 2022
BUY
$7.38 - $10.4 $15.5 Million - $21.8 Million
2,099,705 New
2,099,705 $15.8 Million
Q1 2022

May 16, 2022
SELL
$7.33 - $9.39 $7.7 Million - $9.86 Million
-1,049,916 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$7.9 - $10.19 $8.14 Million - $10.5 Million
1,030,470 Added 5299.14%
1,049,916 $8.41 Million
Q3 2021

Nov 15, 2021
BUY
$8.38 - $10.18 $162,957 - $197,960
19,446 New
19,446 $190,000
Q3 2019

Nov 14, 2019
SELL
$6.16 - $9.6 $11.9 Million - $18.6 Million
-1,935,491 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$8.12 - $15.72 $15.7 Million - $30.4 Million
1,935,491 New
1,935,491 $17.9 Million
Q3 2018

Nov 14, 2018
SELL
$21.06 - $25.65 $536,693 - $653,664
-25,484 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$16.77 - $24.71 $427,366 - $629,709
25,484 New
25,484 $620,000

Others Institutions Holding TEVA

# of Institutions
617
Shares Held
563M
Call Options Held
25.2M
Put Options Held
5.08M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email